This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit February 13, 2015
Home    About AST    Education    Meetings & Events    Public Policy    Contact Us  

 



SOCIETY NEWS

Last call - Participate in an AST focus group
AST
AST is convening focus groups to discuss your needs and communication preferences as an AST member. These focus groups will be hosted via telephone for your convenience. All participants will be sent an advance copy of the list of the questions that will be covered.

If you are interested in participating, please email Cate Girone at Cgirone@myAST.org and indicate your availability.

ONLY TWO TIMES LEFT! Sign up today:
Wednesday, Feb. 18 from 12-1 p.m. EST
Thursday, Feb. 26 from 12-1 p.m. EST

Your participation is encouraged, as your input will help determine how communications are handled going forward.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




Transition resource list from the Joint Adult-Pediatric Transition of Care Work Group
AST
Whether you are a pediatric provider caring for an adolescent transplant recipient or an adult provider accepting a young adult transplant recipient into your practice, successfully transitioning, transferring, and providing adult care for these patients is an important factor in achieving long term survival. Transition programs have been developed for several chronic conditions and currently more programs are being developed and implemented for solid organ transplant recipients. The Joint Adult-Pediatric Transition of Care Work Group of the Pediatric Community of Practice has provided a list of Web resources with information on transition for the AST membership.

This resource list has been expanded and includes:
  • links to websites for brochures, tools and articles
  • a literature database
  • specific information on developed transition programs in chronic conditions and transplant which are hospital- or community-based.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  UCLA Immunogenetics Center

The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
 


UPCOMING EVENTS IN TRANSPLANTATION


Free February Webinars
AST
Medically Complex Living Donors: Candidacy, Care, and Informed Consent: Tuesday, Feb. 17, 2 p.m. EST.
Register today - free for AST members. Distinguish between “low risk donors” and medically complex living donors, evaluate the meanings of new studies regarding donor risk, and refine the current informed consent process in light of the evolving data.

Donor-Specific Antibodies, C4d and Their Relationship With the Prognosis of Transplant Glomerulopathy: Tuesday, Feb. 24, Noon EST.
Register today for a free discussion of the article above from the January 2015 issue of Transplantation. This journal club is hosted by AST's Transplant Diagnostics Community of Practice.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Understanding FQAPI: Free webinar series through 2015
AST
Join us and ASTS as we host a monthly educational webinar series designed and presented by the Centers for Medicare and Medicaid Services. This series will detail all elements of Quality Assurance and Performance Improvement (QAPI). The next webinar is Wednesday, March 11 and is an overview of the FQAPI worksheet.

Webinars are free to all: membership in AST or ASTS is not required. All webinars will be broadcast live, and the recordings will be made available on demand following the air date. View complete details and register at www.myAST.org/FQAPI.

The content of this presentation is determined independently by CMS: neither the AST nor ASTS have input on the content. We appreciate CMS providing this information to the transplant community and so we are facilitating that process, but that should not be construed as any endorsement of the content by either organization.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


COMMITMENT TO CARE
Raptor's mission is to develop and commercialize life-altering therapeutics that treat rare, debilitating, and often fatal diseases.
LEARN MORE
Advertise here!

To find out how to feature your company in the AST eNewsletter and other advertising opportunities, Contact Tom Crist at 972-402-7724.
MORE


OTHER NEWS


Baxter Healthcare voluntary recall of irrigation sets
AST
UNOS was alerted through the Patient Safety portal that 17 specific lots of irrigation sets manufactured by Baxter Healthcare are subject to a voluntarily recall issued January 14, 2015. These sets are commonly used during lung recoveries but may also be used by other organ recovery teams. The reason for the recall is due to the potential for a failure of the packaging seal if shipped at high altitudes. A packaging failure may result in compromised sterility.

Baxter Healthcare recommends ceasing the distribution and/or use of these sets and removal from inventory. You may return the affected product(s) in return for credit.

Recommended Actions
  • Read the complete recall notice from Baxter Healthcare and review instructions for return of any impacted lots.
  • Do not use any product from the specific lots listed in the notice.
  • Contact Baxter Healthcare at 1-800-422-9837 or the Product Surveillance Group at 1-800-437-5176 with any questions.
You may also find this information in the Patient Safety section of Transplant Pro.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


TRANSPLANT NEWS


US sees declining use of available donor hearts for transplantation, despite a growing waiting list
American Journal of Transplantation
Increasing numbers of people in the United States are developing heart failure, which leads to death within five years in approximately half of patients. While heart transplant waiting lists are becoming longer, a new study published in the American Journal of Transplantation reveals a striking decline in the use of available donor hearts for transplantation in many regions.

Related: Donor hearts going to waste, researchers report (HealthDay News)

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Transfusion transmitted infections in solid organ transplantation
American Journal of Transplantation
While the risk of infectious disease transmission through blood transfusion has been greatly reduced as a result of improved screening methods, transfusion-transmissible infections remain a concern for transplant recipients, especially those receiving multiple transfusions. Although transfusion and transplant recipients are at risk for similar infections, the current reporting requirements for infections transmitted by transfusions and organ transplantation vary greatly and remain distinctly separate with no communication between reporting systems.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation
Kidney International
Although cold ischemia time has been widely studied in renal transplantation area, there is no consensus on its precise relationship with the transplantation outcomes. To study this, we sampled data from 3839 adult recipients of a first heart-beating deceased donor kidney transplanted between 2000 and 2011 within the French observational multicentric prospective DIVAT cohort.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Recent advances in the diagnosis and management of cirrhosis-associated cardiomyopathy in liver transplant candidates: Advanced echo imaging, cardiac biomarkers, and advanced heart failure therapies
Libertas Academia
Patients with end-stage liver disease in need of liver transplantation increasingly are older with a greater burden of cardiac disease and other co-morbidities, which may increase perioperative risk and adversely affect long-term prognosis. Cirrhosis of any etiology manifests hemodynamically as a state of low systemic vascular resistance, with high peripheral, but low central blood volume, leading to a state of neurohormonal activation and high cardiac output, which may adversely affect cardiac reserve under extreme perioperative stress, aptly termed cirrhosis-associated or cirrhotic cardiomyopathy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Donor-derived transmission events in 2013: A report of The Organ Procurement Transplant Network Disease Transmission Advisory Committee
Transplantation
The Organ Procurement Transplant Network Disease Transmission Advisory Committee (DTAC), a multidisciplinary committee, evaluates potential donor-derived transmission events (PDDTE), including infections and malignancies, to assess for donor transmitted events. Reports of unexpected PDDTE to Organ Procurement Transplant Network in 2013 were fully reviewed by DTAC. A standardized algorithm was used to assess each PDDTE from a given donor and to classify each individual recipient from that donor.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: Results from 101 centers
Transplantation
Reports from experienced centers suggest that recipients of an ABO-incompatible living-donor kidney transplant after reduction of ABO antibodies experience no penalty in graft and patient survival versus ABO-compatible transplants, but confirmation that these results can be widely replicated is lacking. Living-donor kidney transplants from ABO-incompatible donors after ABO antibody reduction registered with the Collaborative Transplant Study during 2005 to 2012 were analyzed and compared with (i) a matched group of ABO-compatible transplant recipients and (ii) all ABO-compatible transplants from centers that performed at least five ABO-incompatible grafts during the study period.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Consensus conference on best practices in live kidney donation: Recommendations to optimize education, access, and care (American Journal of Transplantation)
Baseline donor chronic renal injury confers the same transplant survival disadvantage for DCD and DBD kidneys (American Journal of Transplantation)
Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: A national survey (Transplant Infectious Disease)
High-risk age window for mortality in children with cystic fibrosis after lung transplantation (Pediatric Transplantation)

Don't be left behind. Click here to see what else you missed.
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Julie Bernhard, Executive Editor, 469.420.2647  
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
Feb. 6, 2015
Jan. 30, 2015
Jan. 23, 2015
Jan. 16, 2015



Advertisement



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063